Cowen Upgrades Immunogen Inc. (IMGN) to Outperform

Go back to Cowen Upgrades Immunogen Inc. (IMGN) to Outperform

UPDATE: H.C. Wainwright Upgrades Immunogen Inc. (IMGN) to Buy

May 6, 2019 7:06 AM EDT

(Updated - May 6, 2019 7:45 AM EDT)

(updated to add analyst comment)

H.C. Wainwright analyst Debjit Chattopadhyay upgraded Immunogen Inc. (NASDAQ: IMGN) from Neutral to Buy with a price target of $7.00 (from $3.50).

The analyst comments "From current levels, we... More